用MAGE-A3特异性TCR工程T细胞向肝细胞癌:一种治疗方法
Yun Zhou1, Jun Su2, Xiaoning Gan1
1Department of Oncology, School of Medicine, the Second Affiliated Hospital of South China University of Technology (Guangzhou First People's Hospital), Guangzhou, China.
International immunopharmacology
|February 8, 2026
概括
利用针对黑色素瘤相关抗原A3 (MAGE-A3) 的T细胞受体工程T细胞 (TCR-T) 疗法,对肝细胞癌 (HCC) 显示出希望. 这种方法有效地减少了模型中的瘤生长,表明MAGE-A3是HCC的潜在治疗标.
科学领域:
- 免疫治疗是一种免疫疗法.
- 在瘤学瘤学.
- 分子生物学分子生物学
背景情况:
- 肝细胞癌 (HCC) 由于高复发率和晚期诊断,存在重大治疗挑战.
- 目前治疗HCC的疗效有限,需要新的治疗策略.
- 黑色素瘤相关抗原A3 (MAGE-A3) 是一种瘤特异性抗原,被确定为潜在的治疗标.
研究的目的:
- 开发和评估针对肝细胞癌 (HCC) 的MAGE-A3的T细胞受体工程T细胞 (TCR-T) 疗法.
- 研究MAGE-A3特异性TCR-T细胞的抗HCC疗效和潜在机制.
- 评估MAGE-A3作为HCC新型免疫治疗策略的可行标的潜力.
主要方法:
- 通过将TCR基因引入自主T细胞,对MAGE-A3特异的TCR-T细胞进行了基因工程.
- 验证了MAGE-A3表达和HLA受限制的T细胞识别.
- 在试验室中评估了抗原特异性细胞毒性,并在皮下异种移植模型中评估了抗瘤疗效和安全性.
主要成果:
- 在HCC组织中MAGE-A3过度表达与患者存活时间减少 (OS,DSS,RFS) 相关联.
- 改造的MAGE-A3 TCR-T细胞通过p-AKT下调和分裂的Caspase-3激活显示出显著的体外细胞毒性和诱导的亡.
- 在体内,TCR-T疗法有效抑制了瘤进展,没有观察到器官毒性.
结论:
- 这项研究提供了MAGE-A3作为HCC中TCR-T治疗的可行标的第一个证据.
- 特定于MAGE-A3的TCR-T疗法代表了对HCC的有前途的新型免疫治疗策略.
- 这些发现表明这种方法对其他固体瘤的潜在应用.
相关概念视频
01:58Cell Specific Gene Expression
16.6K
Multicellular organisms contain a variety of structurally and functionally distinct cell types, but the DNA in all the cells originated from the same parent cells. The differences in the cells can be attributed to the differential gene expression. Liver cells, whose functions include detoxification of blood, production of bile to metabolize fats, and synthesis of proteins essential for metabolism, must express a specific set of genes to perform their functions. Gene expression also varies with...
16.6K
01:58Cell Specific Gene Expression
5.6K
5.6K
00:49What is Genetic Engineering?
80.3K
Overview
80.3K
01:13Therapeutic Index
6.9K
The therapeutic index of a drug is a key parameter in pharmacology that quantifies the relative safety of a drug by calculating the ratio between the dose that causes toxicity in half the population (50%) to the dose that proves to be effective for half the population (50%). It provides a spectrum of doses for a particular drug ranging from effective to potentially toxic. To illustrate, consider an anticoagulant agent like warfarin. It possesses a narrow window within its therapeutic index to...
6.9K
01:22Target Cell Response to Hormones
5.8K
Hormones intricately bind to receptors on the surface or within target cells, initiating a cascade of cellular responses.
Notably, the cellular response can be regulated by altering the number of receptors expressed in the cell. For example, prolonged exposure to elevated hormone levels results in a gradual decline or down-regulation in the number of receptors for that specific hormone on the cell surface. Conversely, in response to low hormone levels, cells may use up-regulation, producing an...
Notably, the cellular response can be regulated by altering the number of receptors expressed in the cell. For example, prolonged exposure to elevated hormone levels results in a gradual decline or down-regulation in the number of receptors for that specific hormone on the cell surface. Conversely, in response to low hormone levels, cells may use up-regulation, producing an...
5.8K
01:30Therapeutic Communication
8.5K
Communication is a lifelong learning process. Through therapeutic communication, nurses can collect relevant assessment data, provide education and counseling, and interact during nursing interventions. Sending and receiving messages occur through verbal and nonverbal communication techniques and can happen separately or simultaneously.
Verbal communication depends on language or a prescribed way of using words so that people can share information effectively. The critical aspects of verbal...
Verbal communication depends on language or a prescribed way of using words so that people can share information effectively. The critical aspects of verbal...
8.5K